Avadel pharmaceuticals receives u.s. fda approval for nouress

Avadel pharmaceuticals receives u.s. fda approval for nouress™ (av001), a cysteine hydrochloride injection for treating neonate patients requiring total parental nutrition (tpn).

AVDL Ratings Summary

AVDL Quant Ranking